Authors:
Koch, C
Cuppens, H
Rainisio, M
Madessani, U
Harms, HK
Hodson, ME
Mastella, G
Navarro, J
Strandvik, B
McKenzie, SG
Citation: C. Koch et al., European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations, PEDIAT PULM, 31(1), 2001, pp. 1-12
Authors:
Wei, L
Vankeerberghen, A
Cuppens, H
Cassiman, JJ
Droogmans, G
Nilius, B
Citation: L. Wei et al., The C-terminal part of the R-domain, but not the PDZ binding motif, of CFTR is involved in interaction with Ca2+-activated Cl- channels, PFLUG ARCH, 442(2), 2001, pp. 280-285
Authors:
Amaral, MD
Pacheco, P
Beck, S
Farinha, CM
Penque, D
Nogueira, P
Barreto, C
Lopes, B
Casals, T
Dapena, J
Gartner, S
Vasquez, C
Perez-Frias, J
Olveira, C
Cabanas, R
Estivill, X
Tzetis, M
Kanavakis, E
Doudounakis, S
Dork, T
Tummler, B
Girodon-Boulandet, E
Cazeneuve, C
Goossens, M
Blayau, M
Verlingue, C
Vieira, I
Ferec, C
Claustres, M
des Georges, M
Clavel, C
Birembaut, P
Hubert, D
Bienvenu, T
Adoun, M
Chomel, JC
De Boeck, K
Cuppens, H
Lavinha, J
Citation: Md. Amaral et al., Cystic fibrosis patients with the 3272-26A > G splicing mutation have milder disease than F508del homozygotes: a large European study, J MED GENET, 38(11), 2001, pp. 777-782
Authors:
Reynaert, I
Van der Schueren, B
Degeest, G
Manin, M
Cuppens, H
Scholte, B
Cassiman, JJ
Citation: I. Reynaert et al., Morphological changes in the vas deferens and expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in control, Delta F508 andknock-out CFTR mice during postnatal life, MOL REPROD, 55(2), 2000, pp. 125-135
Authors:
Dequeker, E
Cuppens, H
Dodge, J
Estivill, X
Goossens, M
Pignatti, PF
Scheffer, H
Schwartz, M
Schwarz, M
Tummler, B
Cassiman, JJ
Citation: E. Dequeker et al., Recommendations for quality improvement in genetic testing for cystic fibrosis European Concerted Action on Cystic Fibrosis, EUR J HUM G, 8, 2000, pp. S2-S24
Authors:
Dork, T
Macek, M
Mekus, F
Tummler, B
Tzountzouris, J
Casals, T
Krebsova, A
Koudova, M
Sakmaryova, I
Macek, M
Vavrova, V
Zemkova, D
Ginter, E
Petrova, NV
Ivaschenko, T
Baranov, V
Witt, M
Pogorzelski, A
Bal, J
Zekanowsky, C
Wagner, K
Stuhrmann, M
Bauer, I
Seydewitz, HH
Neumann, T
Jakubiczka, S
Kraus, C
Thamm, B
Nechiporenko, M
Livshits, L
Mosse, N
Tsukerman, G
Kadasi, L
Ravnik-Glavac, M
Glavac, D
Komel, R
Vouk, K
Kucinskas, V
Krumina, A
Teder, M
Kocheva, S
Efremov, GD
Onay, T
Kirdar, B
Malone, G
Schwarz, M
Zhou, ZQ
Friedman, KJ
Carles, S
Claustres, M
Bozon, D
Verlingue, C
Ferec, C
Tzetis, M
Kanavakis, E
Cuppens, H
Bombieri, C
Pignatti, PF
Sangiuolo, F
Jordanova, A
Kusic, J
Radojkovic, D
Sertic, J
Richter, D
Rukavina, AS
Bjorck, E
Strandvik, B
Cardoso, H
Montgomery, M
Nakielna, B
Hughes, D
Estivill, X
Aznarez, I
Tullis, E
Tsui, LC
Zielenski, J
Citation: T. Dork et al., Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe, HUM GENET, 106(3), 2000, pp. 259-268
Authors:
Wei, L
Vankeerberghen, A
Jaspers, M
Cassiman, JJ
Nilius, B
Cuppens, H
Citation: L. Wei et al., Suppressive interactions between mutations located in the two nucleotide binding domains of CFTR, FEBS LETTER, 473(2), 2000, pp. 149-153
Authors:
Marie, S
Cuppens, H
Heuterspreute, M
Jaspers, M
Tola, EZ
Gu, XX
Legius, E
Vincent, MF
Jaeken, J
Cassiman, JJ
Van den Berghe, G
Citation: S. Marie et al., Mutation analysis in adenylosuccinate lyase deficiency: Eight novel mutations in the re-evaluated full ADSL coding sequence, HUM MUTAT, 13(3), 1999, pp. 197-202
Authors:
Wei, L
Vankeerberghen, A
Cuppens, H
Eggermont, J
Cassiman, JJ
Droogmans, G
Nilius, B
Citation: L. Wei et al., Interaction between calcium-activated chloride channels and the cystic fibrosis transmembrane conductance regulator, PFLUG ARCH, 438(5), 1999, pp. 635-641
Authors:
Vennekens, R
Trouet, D
Vankeerberghen, A
Voets, T
Cuppens, H
Eggermont, J
Cassiman, JJ
Droogmans, G
Nilius, B
Citation: R. Vennekens et al., Inhibition of volume-regulated anion channels by expression of the cystic fibrosis transmembrane conductance regulator, J PHYSL LON, 515(1), 1999, pp. 75-85
Authors:
Vankeerberghen, A
Lin, W
Jaspers, M
Cuppens, H
Nilius, B
Cassiman, JJ
Citation: A. Vankeerberghen et al., Functional characterization of the CFTR R domain using CFTR/MDR1 hybrid and deletion constructs, BIOCHEM, 38(45), 1999, pp. 14988-14998